This provider's $35.3M in total Medicare payments ranks in the 97th percentile of Clinical Laboratory providers nationally.
Medicare payments to this provider grew 46950% from 2017 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 2694% in 2021
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2017 | $68.56 | $25.47 | 2.69x | $43.09 | $28.6K | 1.1K | 18 |
| 2018 | $28.12 | $13.82 | 2.03x | $14.30 | $289.0K | 20.9K | 68 |
| 2019 | $18.99 | $9.16 | 2.07x | $9.83 | $409.0K | 44.7K | 73 |
| 2020 | $64.61 | $30.54 | 2.12x | $34.07 | $325.3K | 10.7K | 56 |
| 2021 | $446.89 | $366.53 | 1.22x | $80.36 | $9.1M | 24.8K | 51 |
| 2022 | $193.86 | $156.09 | 1.24x | $37.77 | $11.7M | 75.1K | 55 |
| 2023 | $32.55 | $26.58 | 1.22x | $5.97 | $13.4M | 505.9K | 38 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 516.2K | $6.1M | $11.76 | 1.22x |
| 81238 | Gene analysis (coagulation factor ix) full sequence analysis | 4.8K | $2.9M | $592.89 | 1.23x |
| 81307 | Gene analysis (partner and localizer of brca2) full sequence analysis | 3.5K | $2.3M | $662.65 | 1.22x |
| 81411 | Test for detecting genes associated with heart disease, duplication/deletion analysis panel | 1.7K | $2.2M | $1.4K | 1.27x |
| 81321 | Gene analysis (phosphatase and tensin homolog), full sequence analysis | 3.5K | $2.1M | $589.20 | 1.22x |
| 81249 | Gene analysis (glucose-6-phosphate dehydrogenase) full sequence analysis | 3.3K | $1.9M | $589.12 | 1.22x |
| 81223 | Gene analysis (cystic fibrosis transmembrane conductance regular) full gene sequence | 3.3K | $1.6M | $489.95 | 1.22x |
| 81407 | Molecular pathology procedure level 8 | 1.3K | $1.1M | $846.27 | 1.20x |
| 81334 | Gene analysis (runt related transcription factor 1) targeted sequence analysis | 3.3K | $1.1M | $323.53 | 1.22x |
| 81311 | Gene analysis for cancer (neuroblastoma) | 3.3K | $969.4K | $290.41 | 1.22x |
| 81320 | Gene analysis (phospholipase c gamma 2) for common variants | 3.3K | $954.9K | $286.07 | 1.22x |
| 81442 | Gene analysis (noonan syndrome) genomic sequence analysis | 399 | $855.3K | $2.1K | 1.17x |
| 81405 | Molecular pathology procedure level 6 | 2.6K | $782.8K | $301.32 | 1.20x |
| 81404 | Molecular pathology procedure level 5 | 2.7K | $753.8K | $274.80 | 1.20x |
| 81413 | Test for detecting genes associated with heart disease, genomic sequence analysis panel, at least 10 genes | 1.3K | $742.8K | $584.90 | 1.20x |
| 81414 | Test for detecting genes associated with heart disease, duplication/deletion analysis panel, at least 2 genes | 1.3K | $739.3K | $584.90 | 1.20x |
| 81406 | Molecular pathology procedure level 7 | 2.6K | $735.1K | $282.85 | 1.21x |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 3.5K | $685.5K | $197.33 | 1.49x |
| 81279 | Gene analysis (janus kinase 2) targeted sequence analysis | 3.3K | $607.0K | $181.84 | 1.22x |
| 81339 | Gene analysis (mpl proto-oncogene, thrombopoietin receptor) sequence analysis of exon 10 | 3.3K | $607.0K | $181.84 | 1.22x |
This provider submits charges 1.25 times higher than what Medicare actually pays.
A markup ratio of 1.25x means for every $100 Medicare pays, this provider initially charges $125. This is lower than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Clinical Laboratory providers in FL for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Quest Diagnostics Clinical Laboratories Inc | Tampa, FL | $1.0B | ⚠️ Flagged |
| Laboratory Corporation Of America | Tampa, FL | $463.1M | ⚠️ Flagged |
| Quest Diagnostics Clinical Laboratories Inc | Miramar, FL | $417.1M | ⚠️ Flagged |
| American Health S, Llc | Davie, FL | $175.7M | ✓ Clear |
| Ameripath Florida Llc | Pompano Beach, FL | $80.1M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data